Psoriasis Treatment Center of Central New Jersey

4 marketed ·

Quick facts

Ameluz 10% Topical Gel · Dermatology/Oncology
Ameluz is a topical photodynamic therapy agent that generates reactive oxygen species upon light activation to destroy abnormal skin cells.
Enstilar 0.005%-0.064% Topical Foam · Dermatology
Enstilar combines a potent corticosteroid (betamethasone dipropionate) and a vitamin D analog (calcipotriene) to reduce inflammation and normalize skin cell differentiation in psoriasis.
Ilumya Injectable Product · Immunology/Dermatology
Ilumya (tildrakizumab) is a monoclonal antibody that selectively blocks the IL-23 pathway by binding to the p19 subunit of interleukin-23, reducing inflammatory signaling in psoriasis.
Topicort Topical Spray · Dermatology
Topicort (desoximetasone) is a topical corticosteroid that reduces inflammation and suppresses immune responses in the skin.

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Top marketed products include Ameluz 10% Topical Gel, Enstilar 0.005%-0.064% Topical Foam, Ilumya Injectable Product, Topicort Topical Spray.